Goldman Sachs’s Global Cord Blood Corporation CO Stock Holding History

Goldman Sachs’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-69,567	Closed	-$337K	–	5578
2019 Q3	$337K	Buy	+69,567	New	+$365K	﹤0.01%	4630
2018 Q4	–	Sell	-22,132	Closed	-$155K	–	6008
2018 Q3	$155K	Sell	22,132 -1,091	-5%	-$8.2K	﹤0.01%	4992
2018 Q2	$220K	Sell	23,223 -16,856	-42%	-$161K	﹤0.01%	4952
2018 Q1	$409K	Sell	40,079 -5,352	-12%	-$54.7K	﹤0.01%	4604
2017 Q4	$452K	Buy	45,431 +26,295	+137%	+$287K	﹤0.01%	4902
2017 Q3	$213K	Buy	+19,136	New	+$224K	﹤0.01%	5713
2014 Q4	–	Sell	-14,309	Closed	-$70K	–	7442
2014 Q3	$70K	Buy	+14,309	New	+$69.4K	﹤0.01%	6728

Other funds holding CO

JCM

Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs's CO Position: Q4 2019 in Review

Goldman Sachs sold out of Global Cord Blood Corporation (CO) in Q4 2019, closing a stake of 69,567 shares — an estimated $337K sold.

Goldman Sachs first reported a position in CO in Q3 2014 and held it in 7 quarters. The position peaked at $452K in Q4 2017. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

Goldman Sachs reported no remaining Global Cord Blood Corporation position as of Q4 2019 after selling out during the quarter.
Goldman Sachs sold 69,567 Global Cord Blood Corporation shares in Q4 2019, an estimated $337K.
Goldman Sachs first reported a position in Global Cord Blood Corporation in Q3 2014 and held it in 7 quarters.
Goldman Sachs's Global Cord Blood Corporation position peaked at $452K in Q4 2017.
35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.